Predictive Factors for Transition to Conversion Therapy in Hepatocellular Carcinoma Using Atezolizumab Plus Bevacizumab.
LIVER INTERNATIONAL(2024)
Key words
alfa-fetoprotein,atezolizumab,Barcelona clinic liver cancer stage,bevacizumab,cancer-free,child-Pugh score,conversion therapy,hepatocellular carcinoma,real-world practice,tumour response
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined